Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


International medtech competition review

This article was originally published in The Gray Sheet

Executive Summary

The International Trade Commission, at the request of the House Ways & Means Committee, has launched a general fact-finding investigation regarding the competitive conditions affecting U.S. sales and trade of medical devices in principal foreign markets, according to an April 3 release. Japan is highlighted as a market of particular interest, following a hearing held by the committee in September in which the country's regulatory policies on medical technology were criticized as a "non-tariff barrier" (1"The Gray Sheet" Oct. 3, 2005, p. 11). The ITC will examine the most recent five-year period for which data are available, and must provide a report to the committee by March 9, 2007. In addition, the commission will hold a public hearing on the subject July 11...

You may also be interested in...

Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry

Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va

Hanmi And LG Chem Highlight Vaccine Prowess, Novel R&D At JPM

Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.

Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts